It is fair to say that far more individuals aside from the commissioner are instrumental as far as the drug review and ...

“In summary, our science-led strategy is delivering compelling proof points that we are creating a sustainable innovation ...

Weldon has questioned the safety of some vaccines and advocated for limits on abortion. He'll be the first CDC director to ...

Makary is a close ally of Robert F. Kennedy Jr. and a proponent of his “Make America Healthy Again” movement to fight chronic ...

The Food and Drug Administration approved on Friday a new medicine from BridgeBio for patients with a progressive heart ...

A conservative federal judge in Texas has ruled in favor of UnitedHealth Group, saying the federal government unlawfully ...

Sanofi is the third company - along with J&J and Eli Lilly - to attempt to change the way it pays for medicines under the ...

Paul is among the most vocal critics of the National Institutes of Health and former top infectious disease researcher ...

Generative AI poses unique challenges to the FDA's regulatory process: from initial evaluation and review, to post market monitoring.

What happens when the Trump train hits the health care establishment? There’s no doubt that President-elect Trump’s decision ...

In today's biotech news, Prime Editing's CEO promises aggressive defense of patents; Novartis acquires a gene editing startup ...

Today's health news includes autism advocates' response to anti-vaccine sentiment and a trip to the prosthetic nipple factory ...